[Federal Register Volume 60, Number 122 (Monday, June 26, 1995)]
[Notices]
[Page 32986]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 95-15561]



-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health


National Heart, Lung, and Blood Institute; Notice of a Closed 
Meeting

    Pursuant to Section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. Appendix 2), notice is hereby given of the following 
Heart, Lung, and Blood Special Emphasis Panel (SEP) meeting:

    Name of SEP: Lung Specific Drug Delivery Systems for 
Tuberculosis Treatment.
    Date: July 18, 1995.
    Time: 8:00 a.m.
    Place: Hyatt Regency, Bethesda, Maryland.
    Contact Person: Carl A. Ohata, Ph.D., 6701 Rockledge Drive, Room 
7198, Bethesda, Maryland 20892-7924, (301) 435-0297.
    Purpose/Agenda: To review and evaluate grant applications.
    The meeting will be closed in accordance with the provisions set 
forth in secs. 552b(c)(4) and 552b(c)(6), Title 5, U.S.C. 
Applications and/or proposals and the discussions could reveal 
confidential trade secrets or commercial property such as patentable 
material and personal information concerning individuals associated 
with the applications and/or proposals, the disclosure of which 
would constitute a clearly unwarranted invasion of personal privacy.

(Catalog of Federal Domestic Assistance Programs Nos. 93.837, Heart 
and Vascular Diseases Research; 93.838, Lung Diseases Research; and 
93.839, Blood Diseases and Resources Research, National Institutes 
of Health.)

    Dated: June 19, 1995.
Susan K. Feldman,
Committee Management Officer, NIH.
[FR Doc. 95-15561 Filed 6-23-95; 8:45 am]
BILLING CODE 4140-01-M